CE-FA Journal - Journal of Dental Research

CE-FA Journal - Journal of Dental Research

Instructions for Authors

 

Submissions are free and there are no article processing charges. All information and opinionsin published articles in the journal are the knowledge and opinions of the author(s). The Editor-in-Chief, Editors, Editorial Board and Publisher accept no responsibility or liability for the information provided by the authors.

Manuscripts sent for publication must not be published previously, accepted for publication, or be under consideration elsewhere. Manuscripts that were presented in a meeting should be submitted with detailed information of the meeting including name, date and location.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication.

The aim of the journal is to create a platform and forum for dental students, dentists and specialists to introduce, share and discuss current developments and contemporary treatments in different areas of dentistry.

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation web site, available at https://www.cefajournal.com

Manuscripts submitted via any other medium will not be considered. Online submission system enables authors to submit and track the progress of their manuscript.

The ORCID (Open Researcher and Contributor ID) number of all authors should be provided on the title page while sending the manuscript. A free registration can be done at http://orcid.org

 

IMPORTANT NOTICE: 


Manuscripts that do NOT include an Ethical Approval, institution name, decision date and ID number will not be evaluated for peer-review.

CLINICAL ARTICLES (randomized or non-randomized clinical trials) must respectively follow CONSORT or TREND guidelines. The authors must mention this in the 

Materials and Methods.

Short communications involving patients and clinical studies should include a statement regarding signed informed consent.

Ethical Approval and Declaration of Helsinki should be considered for articles involving clinical research (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethicalprinciples- for-medical-research-involving-human-subjects/). Patient identifiers (e.g.full name, abbreviations, or patient number) should not be included in the article or on the photographs. When there is no patient approval, eyes should be hidden with black strips.

Animal studies should be in accordance with the international ethical standards and an ethical approval is necessary with institution name, decision date and ID number that should be included in the Materials and Methods.

REVIEW PROCESS
All manuscripts submitted to the CE-FA Journal should be screened for similarity by the authors using an appropriate Software like iThenticate or Turnitin, and the final report showing a similarity percentage less than 15% should be included in the submission.

Journal of Dental Insight uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. The manuscripts should be free of any information that will allow identification of the author(s). Editor(s) will email selected reviewers, the title and abstract of the submission, as well as an invitation to log into the journal web site to complete the review process. Reviewers will log in to the CE-FA Journal’s web site in order to agree to do the review, download submissions, submit their comments, and select a recommendation. The typical period of time for a review process is 8 weeks.

LANGUAGE
All publications should be in English . Authors whose native language is not English, should consider to obtain the assistance of an expert in English and scientific writing before submitting their manuscripts. Manuscripts that do not meet basic language standards will be returned during editorial reviews.

Manuscripts should be sent in "doc" or "docx” format. The article should contain the following sections:

TITLE PAGE

Type of the article : Eg. Short communication. If the article was presented at a scientific meeting name, date and location should be specified here.

Title: Concise (should not be longer than 12 words) and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Running title: The running title should not exceed 50 letters and spaces

Author names and affiliations: Full names of the authors including academic degrees. The institutional affiliation of the authors (including city and country) must be given just below the names row, relating to a superscript number indicated after the surname. ORCID identifiers of all the authors should be included. You can get one or check yours at https:// orcid.org/

Corresponding author: Clearly indicate who will handle correspondence at all stages of refereeing, publication and post-publication. Ensure that the e-mail address is given and that contact details (mailing address, full postal address, office phone, and cell phone numbers) are kept up to date by the corresponding author.

Funding source: Specify the grant number, protocol number, etc.

Conflict of interest statement: It may read: “No author of this article has a conflict of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included in the manuscript”. If this is not the case, any conflict of interest must be specified; for example: “Author A owns stock in X company, Author B has received, within 2 years, consulting fees from Y company that manufactures a competing product to the one discussed in this article” etc.

Acknowledgements: Acknowledegements may include, for example, any previous presentation of the article in full reference, any non-author contributor of the article, etc. and all documents related to the financial support should be included.

Ethical approval: Provide the ethical review board information (full name, approval date, and number) here and in the text. Clinical trial registration information including registration site (e.g. clinicaltrials.gov), registration number, date of registration and internet link (recommended).

ABSTRACTS AND KEYWORDS

Abstract for Original Article and Review Articles: The abstract must accurately reflect the contents of the article and must not include information that does not appear in the body of the paper. The aim of the study, basic procedures, main findings, and principal conclusions drawn from the study should be stated
concisely. The abstract should not exceed 250 words and must be structured using the headings below. However abstracts of Review Articles should be unstructured. • Introduction: Give a clear statement of the main aim of the study and the main hypothesis tested, if any.
• Materials and Methods: Describe the methods adopted including the design and setting of
the study, entry requirements for subjects, use of materials, outcome measures and statistical
tests as appropriate.
• Results: Give the main results of the study, including the outcome of any statistical analysis.
• Conclusions: Main conclusions and their implications should be stated. Suggest areas for
further research, if appropriate.

Abstract For Leading Articles And Short Communications: The abstract should not exceed 150 words. Provide a short, non-structured, 1-paragraph abstract that briefly summarises the study.

Provide a maximum of 6 keywords. Keywords should be selected from the Medical Subject Headings (MESH; www.nlm.nih.gov/mesh/MBrowser.html) and should be listed in alphabetical order, and separated with a semicolon (;). Keywords should not be chosen from the title and the abstract, since those are automatically indexed; instead, should be chosen from the text.

INTRODUCTION
The introduction section should be focused, outlining the historical or logical origins of the study and gaps in knowledge. Provide only directly pertinent references, and do not include data or conclusions from the work being reported. Exhaustive literature reviews are not appropriate. Clearly state the aim of the study in the last paragraph of the section, and give the research hypothesis, where applicable. All acronyms and abbreviations should be defined at first use, in the main text by using parentheses following the definition.

MATERIALS AND METHODS
This section is intended to allow other investigators to repeat your experiments. Identify the source of the material or equipment used (name, product number, and batch, manufacturer, city, and country, in parentheses). Give references to established methods or describe new or modified methods.

Please add the full name of the Ethics Committee from which the approval was obtained and the decision number if any.

In the last paragraph of the materials and methods section, the statistical analysis (if applicable), should be described in sufficient detail. Define statistical terms, abbreviations, and symbols. Specify the computer software used. It is recommended that the authors consult a statistician for the analysis of their data.

RESULTS
The findings should be presented in a clear and concise manner. For this purpose, tables, graphs and photos could be used. All of them must be cited in the text in numerical order and include a brief description of the major findings.

DISCUSSION
The importance of the findings should be noted avoiding any restatements. Agreements with other studies and the limitations of the present study should be noted, while suggesting areas for future research.

CONCLUSIONS
The authors should briefly state the general interpretation of the results and important implications.

ACKNOWLEDGEMENTS
If the work was supported by a grant or any other kind of funding, supply the name of the supporting organisation and the grant number. Any potential conflicts of interest should be noted. If there are no conflicts of interest, please add specific wording: "The authors deny any conflicts of interest related to this study."

REFERENCES
References should be numbered in the order they are cited. Only published data or manuscripts accepted for publication and recent data should be included. All references must be easily retrievable from one of the standard databases (for example, PubMed, Google Scholar, or Science Direct). Inaccessible data sources and those not indexed in any database should be omitted. No references should be cited in the abstract. Each reference should be cited only once; on subsequent citations, the original number should be used.

Reference style should be set out in Vancouver style, superscripted in the text before punctuation marks, and numbered in the order in which they appear in the text. 
All authors should be listed if an article has three or less authors; if an article has more than three authors, first three authors are listed and the rest is represented by “et al.” 

 

TABLES / GRAPHS / ILLUSTRATIONS / PHOTOGRAPHS

Tables and figures should be located at the end of the main document, after the references section. Images should be submitted in JPG or TIFF formats.

All figures (photographs, graphs, drawings, etc) and tables must be numbered consecutively with Roman numerals according to the order they appear in the text.

Tables should not be a repetition of the main text, but should be supporting it. All tables must be thoroughly discussed in the text of the manuscript. Table captions should be placed above the table.

Explanatory material including abbreviations, statistical information (statistical analysis method, p values, etc) must be given in footnotes placed above the table, not in the table heading. An asterisk (*) or superscript letter may be used where appropriate.

Figure legends should be placed below the relevant figure.

In case the manuscript contains images of persons, written permission for their use must be obtained and submitted with the manuscript. Legal, financial and criminal liabilities in this regard belong to the author(s).